Skip to content
BLACK BOOK
Menu
manufacturer✓ Verified☎ Contact on file

Acumen Pharmaceuticals, Inc.

Biological Products, (No Diagnostic Substances) · Newton, MA, United States

  1. PrincipalsAmy SchacterleChief Regulatory OfficerDaniel Joseph OConnellChief Executive OfficerDerek M MeisnerChief Legal Officer & Corp Secand 7 more
  2. CompanyAcumen Pharmaceuticals, Inc.Newton, MA, United States
  3. Phone line+1 (617) 344-4190General business
Request a quote

Acumen Pharmaceuticals, Inc. is an SEC-registered Nasdaq-listed company (ticker ABOS) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 10

Chief executive

Daniel Joseph OConnellChief Executive Officer
James J. DohertyPresident and CDO

Chair & board

George GolumbeskiDirector (Board)
Peter KolchinskyDirector (Board)
Rajeev M. ShahDirector (Board)

Finance

Matt ZugaCFO & Chief Business Officer

Operations

Russell BartonChief Operating Officer

Legal

Derek M MeisnerChief Legal Officer & Corp Sec
Everyone else on file (2)
Amy SchacterleChief Regulatory Officer
Eric SiemersChief Medical Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗

  2. Derek M Meisner — Chief Legal Officer & Corp Sec

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

  3. Daniel Joseph OConnell — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

  4. Eric Siemers — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

  5. Amy Schacterle — Chief Regulatory Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers

Adaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capability